Joanne Zhang

Author PubWeight™ 10.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statistical issues of QT prolongation assessment based on linear concentration modeling. J Biopharm Stat 2008 1.43
2 Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability. Heart Rhythm 2011 1.42
3 Statistical characteristics of moxifloxacin-induced QTc effect. J Biopharm Stat 2010 1.32
4 Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects. Am Heart J 2012 0.98
5 Thorough QT Studies: Questions and Quandaries. Drug Saf 2010 0.94
6 The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing. Am Heart J 2010 0.85
7 Practice and challenges of thorough QT studies. J Electrocardiol 2012 0.84
8 Cardiovascular function in nonclinical drug safety assessment: current issues and opportunities. Int J Toxicol 2011 0.78
9 Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials. J Biopharm Stat 2010 0.78
10 Comment on 'New confidence bounds for QT studies' by Dennis D. Boos, David Hoffman, Robert Kringle and Ji Zhang, Statistics in Medicine 2007; 26:3801-3817. Stat Med 2009 0.75
11 Guest editors' notes on statistical issues in design and analysis of thorough QTc studies. J Biopharm Stat 2008 0.75
12 Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes. J Biopharm Stat 2010 0.75
13 Choice of delta noninferiority margin and dependency of the noninferiority trials. J Biopharm Stat 2007 0.75
14 Choice of lambda-margin and dependency of non-inferiority trials. Stat Med 2008 0.75
15 Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials. J Biopharm Stat 2007 0.75